MARGARET WILK: Open Payments
NPI 1912636291 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$553 in 33 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $142 · 2025 $553
Food & beverage: $553
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $143 |
| Novo Nordisk Inc | 4 | $78 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| Amgen Inc. | 3 | $49 |
| PFIZER INC. | 2 | $40 |
| ABIOMED | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $32 |
| Exact Sciences Corporation | 1 | $27 |
| Corcept Therapeutics | 1 | $27 |
Products named: UBRELVY, Ozempic, REXULTI, OTEZLA, TRELEGY ELLIPTA, CAPLYTA, The Cologuard Plus Collection Kit, Korlym.
Industry payments across MI — which companies pay providers there.
